Patanjali Case: Court Asks Ramdev, Balkrishna To Appear On Aug 6

Kozhikode: The case relating to ‘misleading’ advertisements of Patanjali Ayurved’s products in the media will be heard on August 6.

The Kozhikode court on Monday issued summons to Yoga guru Ramdev and his associate Acharya Balkrishna to appear before the court on this date. The order comes after the two failed to appear before the court today as directed earlier. The summons order was issued by the Kozhikode Judicial First Class Magistrate Court.

Ramdev, founder is the second accused in the case and Balkrishna is the third accused. The marketing wing of Patanjali Ayurved, Divya Pharmacy, is the first accused.

The Office of the Assistant Drugs Controller, Kozhikode lodged a complaint based on which a case was registered under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 in April.

In February, the Supreme Court had issued a contempt notice against Patanjali Ayurved and restrained it from publishing advertisements of medicines used for treatment of ailments including blood pressure, asthma, arthritis and obesity.

The first complaint against Divya Pharmacy was filed in February 2022 by KV Babu, an ophthalmologist from Kannur. He had lodged a complaint at the State Drug Control Department. Following which, the State Drug Control Department had ordered an inquiry and instances of violation of the Act surfaced.

Related Posts

Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.…

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre

US FDA launches expedited IND Pilot, begins accepting applications

US FDA launches expedited IND Pilot, begins accepting applications

PIL in SC seeks time-bound probe, stringent action against fake drug networks

PIL in SC seeks time-bound probe, stringent action against fake drug networks

Ghaziabad: Fake supplement racket busted, 5 held

Ghaziabad: Fake supplement racket busted, 5 held

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

22 medical stores raided in Hisar, 7 stocked dual-use drugs without records